leisure time -WSS

leisure time

author：leisure time 2025-09-02 11:45:16 - browse：441

Vertex Pharmaceuticals - sunset — Bill Sikes/AP

LONDON — Regulators in the U.K. on Thursday approved a CRISPR-based medicine to treat both sickle cell disease and beta thalassemia, making it the world’s first therapy built on the revolutionary gene-editing technology and ushering in a new era of genetic medicine.

The authorization of the therapy, from Vertex Pharmaceuticals and CRISPR Therapeutics, is itself not a surprise. Clinical trials have shown the one-time treatment enabled many sickle cell patients to live free of debilitating pain crises and relieved thalassemia patients of needing regular blood transfusions, raising hopes that they have been effectively cured. But it also stands as a major achievement, coming just over a decade after the first and seminal lab experiments that showed CRISPR’s potential as a gene-editing tool were published.

In granting conditional approval to the therapy, which will have the brand name Casgevy and is also known as exa-cel, the U.K.’s Medicines and Healthcare products Regulatory Agency jumped ahead of its counterparts in the U.S. and Europe, which are also reviewing the medicine, in greenlighting the globe’s first CRISPR treatment. The MHRA’s authorization is for patients who are at least 12 years old.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Why ADHD is under

focus

WSS

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

Putin woos African leaders at a summit in Russia with promises of expanding trade and other ties

N.Y. state detects polio case, first in the U.S. since 2013

Charles Manson follower Leslie Van Houten released from prison after 53 years

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

Biden launches a new push to limit health care costs

focus

leisure time

hotspot

What does generative AI mean for health care? We asked experts

What AstraZeneca

How to save PrEP access — and even expand it

Retired US general questions alleged Putin, Prigozhin meeting

Activists slam private health insurers over coverage restrictions

How the political right came to back psychedelics to treat trauma

Anesthesiologist group: stop taking Ozempic before surgery

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

New air purifier tech could be key to improving indoor air quality

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

focus

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

Biden launches a new push to limit health care costs

Bulgari apologizes to China for listing Taiwan as a country after online backlash

It's time to get medical device identifiers over the finish line

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

Why ADHD is under

focus

focus

focus

Wikipedia